文献速递妇科

美国微创附件手术应用趋势

Trends in the Use of Minimally Invasive Adnexal Surgery in the United States.
PubMed 文献 · Obstet Gynecol · 2021-01-01

该研究基于2016至2018年美国全国门诊和住院手术数据库,纳入因良性卵巢病变行卵巢囊肿切除或卵巢切除术的女性,排除妇科恶性肿瘤或同期子宫切除者。结果显示微创手术在两种术式中均占多数,且比例逐年上升,微创手术并发症率显著低于开腹手术。

要点

  • 微创手术在卵巢囊肿切除中占89.6%,在卵巢切除中占87.3%。
  • 2016至2018年微创手术比例逐年上升,囊肿切除从88.7%升至91.0%,卵巢切除从85.8%升至88.7%(P<.001)。
  • 微创手术并发症率低于开腹手术:囊肿切除2.7% vs 8.8%,卵巢切除3.1% vs 22.9%(P<.001)。

核心结论

  • 微创手术是大多数良性附件手术的选择,且与开腹手术相比并发症更少。

研究设计与样本

  • 基于美国全国门诊手术样本和全国住院样本数据库的回顾性队列研究,纳入2016至2018年因良性卵巢病变行卵巢囊肿切除或卵巢切除术的女性,排除妇科恶性肿瘤或同期子宫切除者。

主要发现

  • 加权后全国代表547,836例卵巢切除术和328,408例囊肿切除术患者。
  • 微创手术在卵巢囊肿切除中占89.6%(294,190例),在卵巢切除中占87.3%(478,402例)。
  • 囊肿切除微创比例从2016年88.7%升至2018年91.0%,卵巢切除从85.8%升至88.7%(P<.001)。
  • 卵巢囊肿切除并发症率微创2.7% vs 开腹8.8%(P<.001);卵巢切除微创3.1% vs 开腹22.9%(P<.001)。

临床怎么用

  • 对于良性附件手术,应优先考虑微创途径以降低并发症风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To examine the utilization of minimally invasive adnexal surgery, including ovarian cystectomy and oophorectomy, among women with benign gynecologic diseases and compare the associated morbidity and mortality of minimally invasive and open surgery. METHODS: Women with benign ovarian pathology who underwent an ovarian cystectomy or oophorectomy from 2016 through 2018 in the Nationwide Ambulatory Surgery Sample and Nationwide Inpatient Sample databases were included. Patients with a diagnosis of gynecologic malignancy or concurrent hysterectomy were excluded. Population-level weighted estimates were developed, and perioperative morbidity, mortality, and hospital charges were examined based on surgical approach for each procedure. RESULTS: The cohort included 351,207 women who underwent oophorectomy and 220,893 women who underwent cystectomy, when weighted representing 547,836 and 328,408 patients, respectively, nationwide. A minimally invasive surgical approach was used in 294,190 (89.6%) patients who underwent ovarian cystectomy, and in 478,402 (87.3%) of patients who underwent oophorectomy. Use of minimally invasive surgery for cystectomy increased from 88.7% in 2016 to 91.0% in 2018, and the rate of minimally invasive surgery for oophorectomy increased from 85.8% to 88.7% over the same time period (P<.001 for both). The complication rates for ovarian cystectomy were 2.7% for minimally invasive surgery and 8.8% for laparotomy (P<.001); for oophorectomy the complication rate was 3.1% for minimally invasive surgery and 22.9% for laparotomy (P<.001). CONCLUSION: Minimally invasive surgery is used in the majority of women who are undergoing oophorectomy and ovarian cystectomy for benign indications. Compared with laparotomy, minimally invasive surgery is associated with fewer complications.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Dioun S, Huang Y, Melamed A, et al. Trends in the Use of Minimally Invasive Adnexal Surgery in the United States. Obstet Gynecol. 2021. PMID: 34619737. doi:10.1097/AOG.0000000000004577

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。